Volume 1, Issue 2

• Long-Term Outcome of Family Therapy in Schizophrenia
  Author(s): Mª Jose Masanet, Isabel Montero, Maria Lacruz, Francisco Bellver,Ildelfonso Hernández
  • Abstract
  • PDF
• Assessing Intimidation Using a Brief Intrusiveness Measure
  Author(s): David I. Mayerhoff, Jeffry R. Nurenberg
  • Abstract
  • PDF
• Antipsychotic Combination with Psychosocial Intervention on Outcome of Schizophrenia (ACPIOS): Rationale and Design of the Clinical Trial
  Author(s): Xiaofeng Guo, Jingping Zhao, Zhening Liu, Jinguo Zhai, Zhimin Xue,Jindong Chen
  • Abstract
  • PDF
• Psychosis Following the Addition of Pramipexole in an Intellectually Disabled Adult
  Author(s): Nancy C. Brahm, Gary A. Fast, Robert C. Brown
  • Abstract
  • PDF
• Clozapine and Dilated Cardiomyopathy
  Author(s): Jonathan M. Meyer, Sanjai D. Rao, Jimmi R. Nielsen
  • Abstract
• Factors Associated with Dropout and Noncompliance in Patients with Schizophrenia: Results of a One-Year Follow-Up
  Author(s): Alp �?çok, Kazim Yazici, Levent Mete, Savas Kültür, A. Kemal Gögüs, Sahap Erkoç, Köksal Alptekin
  • Abstract
  • PDF
• Critical Issues in the Assessment of Disability in Schizophrenia
  Author(s): Margaret M. McClure, Philip D. Harvey
  • Abstract
  • PDF
• Clinical Pharmacology and MedicationAssociated Side Effects: A Review of Second-Generation Antipsychotics for Schizophrenia
  Author(s): Robert R. Conley, Deanna L. Kelly
  • Abstract
  • PDF
• New Indications for Antipsychotic Use in Adolescents
  Author(s): Robert R. Conley
  • Abstract
  • PDF